Tyler Zeronda
Director Financiero/CFO en VYNE THERAPEUTICS INC. .
Fortuna: 325 405 $ al 30/04/2024
Cargos activos de Tyler Zeronda
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| VYNE THERAPEUTICS INC. | Director Financiero/CFO | 18/06/2021 | - |
| Treasurer | 18/06/2021 | - |
Historial de carrera de Tyler Zeronda
Antiguos cargos conocidos de Tyler Zeronda.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| AERIE PHARMACEUTICALS, INC. | Director Financiero/CFO | - | - |
Formación de Tyler Zeronda.
| University of Virginia | Graduate Degree |
| Lafayette College | Undergraduate Degree |
Estadísticas
Internacional
| Estados Unidos | 5 |
Operativa
| Director of Finance/CFO | 2 |
| Treasurer | 1 |
| Graduate Degree | 1 |
Sectorial
| Health Technology | 3 |
| Consumer Services | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| VYNE THERAPEUTICS INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Aerie Pharmaceuticals, Inc.
 Aerie Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aerie Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of therapies for the treatment of patients with open-angle glaucoma, retinal diseases and other diseases of the eye. Its products include Rhopressa, Roclatan, AR-13503, and AR-1105. The company was founded by David L. Epstein, Casey C. Kopczynski, Thomas J. van Haarlem, and Eric J. Toone on January 1, 2005 and is headquartered in Durham, NCForth Worth, TX. | Health Technology |
- Bolsa de valores
- Insiders
- Tyler Zeronda
- Experiencia
